
Cadeltro 25mg Tablet
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Eltrombopag (25mg)
Overview Cadeltro 25mg Tablet
Eltrombopag 25mg tablets are indicated for managing low platelet counts stemming from chronic immune thrombocytopenic purpura (ITP) or chronic hepatitis C (HCV) infection. This medication also addresses severe aplastic anemia. Acting as a thrombopoietin receptor agonist, Eltrombopag 25mg stimulates platelet production, thereby aiding in hemostasis. Adhere strictly to your physician's prescribed dosage and regimen. Administration may occur on an empty stomach. Swallow the tablet whole; avoid crushing, chewing, or breaking. Report any allergies to this drug to your doctor. Common adverse reactions encompass nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Discuss any bothersome side effects with your doctor; management strategies may be available. Prior to initiating therapy, disclose any underlying health conditions and all concurrently used medications. Dosage modifications might be necessary for individuals with hepatic impairment; consult your physician.
Primary Ingredients of Cadeltro 25mg Tablet
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Cadeltro 25mg Tablet
Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; Management of critical bone marrow failure
Major Benefits of Cadeltro 25mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cadeltro 25mg tablets should be taken on an empty stomach.
Common Side effects of Cadeltro 25mg Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Cadeltro 25mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Cadeltro 25mg Tablet on an empty stomach.
How Cadeltro 25mg Tablet works:
Cadeltro 25mg tablets function as a thrombopoietin receptor activator, promoting increased platelet production within the bloodstream. This heightened platelet count contributes to decreased bleeding risk.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cadeltro 25mg Tablet may pose unknown safety risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Cadeltro 25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Cadeltro 25mg Tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Cadeltro 25mg Tablet, which can induce dizziness and reduced alertness, impacting safe operation of a vehicle.
KidneySAFE IF PRESCRIBED
Cadeltro 25mg tablets can be used by patients with kidney disease without altering the dosage. Nevertheless, disclosure of kidney disease to your physician is recommended. Routine monitoring of kidney function is advisable during treatment.
LiverCAUTION
Patients with hepatic impairment should use Cadeltro 25mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Cadeltro 25mg Tablet :
Omit any missed Cadeltro 25mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Cadeltro 25mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Biphenyl Derivatives |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Action Class | Thrombopoietin receptor activator |
